A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice

Journal of Autoimmunity

Volumn 9, Issue 3, 1996, Pages 331-339

  Han, Hye Seung ^a   Jun, Hee Sook ^a   Utsugi, Toshihiro ^a   Yoon, Ji Won ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

B cell specific autoimmunity; CD4+ suppressor; IDDM; Islet transplantation; NOD mouse; T cell; TGF

Indexed keywords

CD4 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; AUTOIMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; SUPPRESSOR CELL;

EID: 0030175335     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0045     Document Type: Conference Paper

References (51)

1. 1. Kataoka S, Satoh J, Fujiya H, Toyota T, Suzuki R, Itoh K, Kumagai K. 1983. Immunological aspects of the nonobese diabetic (NOD) mouse: abnormalities of cellular immunity. Diabetes 32: 247-253
2. 2. Kikutani H, Makino S. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51: 285-322
3. 3. Bach J.F. 1994. Insulin dependent diabetes mellitus as an autoimmune disease. Endocrine Reviews 15: 516-542
4. 4. Rossini A.A., Greiner D.L., Friedman H.P., Mordes J.P. 1993. Immunopathogenesis of diabetes mellitus. Diabetes Reviews 1: 43-75
5. 5. Yoon J.W., Park Y.H., Santamaria P. 1995. Autoimmunity of type I diabetes: In: Flatt PR., Ioannides C, Eds. Drugs, diet and disease Vol 2. Mechanistic approaches to diabetes. London: Ellis Howard of Simon and Schuster International Group, pp 57-97
6. 6. Koike T., Itoh Y., Ishii T., Ito I., Takabayashi K., Maruyama T., Tomoika H., Yoshida S. 1987. Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 36: 539-541
7. 7. Shizuru J.A., Taylor-Edwards C., Banks B.A., Gregory A.K., Fathman G.G. 1988. Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to T-helper lymphocytes. Science 240: 659-662
8. 8. Wang Y., Hao L., Gill R.G., Lafferty K.J. 1987. Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36: 535-538
9. 9. Haskins K., McDuffie M. 1990. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T-cell clone. Science 249: 1433-1436
10. 10. Katz J.D., Banoist C., Mathis D. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1190
11. 11. Nagata M., Yoon J.W. 1992. Studies on autoimmunity for T cell-mediated β cell destruction. Distinct difference in β cell destruction between CD4+ and CD8+ T cell clones derived from lymphocytes infiltrating the islets of NOD mice. Diabetes 41: 998-1008
12. 12. Nagata M., Santamaria P., Kawamura T., Utsugi T., Yoon J.W. 1994. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta cells in NOD mice. J. Immunol. 152: 2042-2050
13. 13. Santamaria P., Utsugi T., Park B.J., Averill N., Kawazu S., Yoon J.W. 1995. Beta cell-cytotoxic CD8+ T cells from non-obese-diabetic mice use highly homologous T-cell receptor α-chain CDR3 sequences. J. Immunol. 154: 2492-2503
14. 14. Utsugi T., Yoon J.W., Park B.J., Imamura M., Averill N., Kawazu S., Santamaria P. 1995. MHC class I restricted inflammation and destruction of histocompatible islet grafts in diabetes-resistant mice by NOD mouse-derived beta cell cytotoxic CD8+ T lymphocytes. Diabetes: in press
15. 15. Wong S., Visintin I., Wen L., Flavell R.A., Janeway C.A. Jr. 1995. CD8 T cell clones from young non obese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 T cells. J. Exp. Med. 183: 67-76
16. 16. Boitard C., Yasunami R., Dardenne M., Bach J.F. 1989. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169: 1669-1680
17. 17. Hutchings P.R., Cooke A. 1990. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmunity 3: 175-185
18. 18. Reich E.P., Scaringe D., Yagi J., Sherwin R.W., Janeway C.A. Jr. 1989. Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes 38: 1647-1651
19. 19. Akhtar I., Gold J.P., Pan L., Ferrara J.L.M., Yang X., Kim J.I., Tan K. 1995. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 182: 87-97
20. 20. Pankewycz O., Strom T.B., Rubin-Kelley V.E. 1991. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes. Eur. J. Immunol. 21: 873-879
21. 21. Yoon J.W., Lesniak M.A., Fussganger R., Notkins A.L. 1976. Genetic differences in susceptibility of pancreatic beta-cell to virus-induced diabetes mellitus. Nature 264: 178-180
22. 22. Kawamura T., Nagata M., Utsugi T., Yoon J.W. 1993. Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated non-obese diabetic mice. J. Immunol. 151: 4362-4370
23. 23. Lee K.U., Amano K., Yoon J.W. 1988. Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes 37: 989-991
24. 24. Gotoh M., Maki T., Kiyoizumi T., Satomi S., Monaco A.P. 1985. An improved method for isolation of mouse pancreatic islets. Transplantation 40: 437-438
25. 25. Utsugi T., Nagata M., Kawamura K., Yoon J.W. 1994. Prevention of recurrent diabetes in syngeneic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes. Transplantation 57: 1799-1804
26. 26. Wang T., Singh B., Warnock G.L., Rajotte R.V. 1992. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 41: 114-117
27. 27. Chomczynski P., Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyantate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159
28. 28. Wesselingh S.L., Levine B., Fox R.J., Choi S., Griffin D.E. 1994. Intercerebral cytokine mRNA expression during fatal and nonfatal alpha-virus encephalitis suggests a predominant type 2 T cell response. J. Immunol. 152: 1289-1297
29. 29. Epstein S.P., Baer R.L., Thorbecke G.J., Belsito D.V. 1991. Immunosuppressive effects of transforming growth factor beta: Inhibition of the induction of Ia antigen on Langerhans cells by cytokines and of the contact hypersensitivity response. J. Invest. Dermatol. 96: 832-837
30. 30. Czarniecki C.W, Chiu H.H., Wong G.H.W, McCabe S.M., Palladino M.A. 1988. Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140: 4217-4223
31. 31. Cai J.P., Falanga V., Chin Y.H. 1991. Transforming growth factor beta regulates the adhesive interactions between mononuclear cells and microvascular endothelium. J. Invest. Dermatol. 97: 169-174
32. 32. Fabry Z., Topham D.J., Fee D., Herlein J., Carline J.A., Hart M.N., Sriram S. 1995. TGF-β2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J. Immunol. 155: 325-332
33. 33. Rook A.H., Kehrl J.H., Wakefield L.M., Roberts A.B., Sporn M.B., Burling D.B., Lane H.C., Fauci A.S. 1986. Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136: 3916-3920
34. 34. Kasid A., Bell G.I., Director E.P. 1988. Effects of transforming growth factor β on human lymphokine activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells. J. Immunol. 141: 690-698
35. 35. Boutard V., Harouis R., Fouqueray B., Philippe C., Moulinoux J-P., Baud L. 1995. Transforming growth factor-β stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J. Immunol. 155: 2077-2084
36. 36. Vodovotz Y., Bogdan C., Paik J., Xie Q-W., Nathan C. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-β. J. Exp. Med. 178: 605-613
37. 37. Thorbecke G.J., Shah R., Leu C.H., Kuruvilla A.P., Hardison A.M., Palladino M.A. 1992. Involvement of endogenous tumor necrosis factor-α and transforming growth factor-β during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA 89: 7375-7379
38. 38. Johns L.D., Flanders K.C. Ranges R.E., Sriram S. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J. Immunol. 147: 1792-1796
39. 39. Santambrogio L., Hochwald G.M., Saxena B., Leu C.H., Martz J.E., Carlino J.A., Ruddle N.H., Palladino M.A., Gold L.I., Thorbecke G.J. 1993. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J. Immunol. 151: 1116-1127
40. 40. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., Weiner H.L. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240
41. 41. Pennline K.J., Roque-Gaffney E., Monahan M. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71: 169-175
42. 42. Mignon-Godefroy K., Rott, O., Brazillet M-P., Charreire J. 1995. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT): Evidence for IL-10 enhanced cell death in EAT. J. Immunol. 154: 6634-6643
43. 43. Fiorentino D.F., Bond M.W., Mosmann T.R. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170: 2081-2095
44. 44. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., O'Garra A. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146: 3444-3451
45. 45. Macatonia S.E., Doherty T.M., Knight S.C., O'Garra A. 1993. Differential effect of interleukin 10 on dendritic cell-induced T-cell proliferation and interferon production. J. Immunol. 150: 3755-3765
46. H1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549
47. 47. Wogensen L., Lee M.S., Sarvetnick N. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in non-obese diabetic mice. J. Exp. Med. 179: 1379-1384
48. 48. Rabinovitch A., Wilma L.S., Sorensen O., Bleackley C., Power R.F. 1995. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154: 4874-4882
49. 49. Campbell I.L., Kay T.W.H., Oxbrow L., Harrison L.C. 1991. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/wehi mice. J. Clin. Invest. 87: 739-742
50. 50. Sarvetnick N., Liggitt D., Pitts S.L., Hansen S.E., Stewart T.A. 1988. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-γ. Cell 52: 773-782
51. 51. Rabinovitch A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: Therapeutic intervention by immunostimulation? Diabetes 43: 613-621.